Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Hagerman

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Genes, Brain, and Behavior|April 3, 2012
Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTASF Tassone, C M Greco, M R Hunsaker, et al.
Neurology|August 29, 2007
Volumetric brain changes in females with fragile X-associated tremor/ataxia syndrome (FXTAS)J S Adams, P E Adams, D Nguyen, et al.
Clinical Genetics|May 26, 2010
Clinical involvement in daughters of men with fragile X-associated tremor ataxia syndromeW Chonchaiya, D V Nguyen, J Au, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|November 13, 2009
Psychological symptoms correlate with reduced hippocampal volume in fragile X premutation carriersP E Adams, J S Adams, D V Nguyen, et al.
Neurology|December 7, 2007
FMR1 CGG repeat length predicts motor dysfunction in premutation carriersM A Leehey, E Berry-Kravis, C G Goetz, et al.
Brain : a Journal of Neurology|December 8, 2005
Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS)C M Greco, R F Berman, R M Martin, et al.
American Journal of Human Genetics|April 6, 2004
Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutationR J Hagerman, B R Leavitt, F Farzin, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 15, 2017
Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia SyndromeJ Y Wang, A M Trivedi, N R Carrillo, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 30, 2021
A white paper on a neurodevelopmental framework for drug discovery in autism and other neurodevelopmental disordersC M Díaz-Caneja, M W State, R J Hagerman, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Genes, Brain, and Behavior|April 3, 2012
Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTASF Tassone, C M Greco, M R Hunsaker, et al.
Neurology|August 29, 2007
Volumetric brain changes in females with fragile X-associated tremor/ataxia syndrome (FXTAS)J S Adams, P E Adams, D Nguyen, et al.
Clinical Genetics|May 26, 2010
Clinical involvement in daughters of men with fragile X-associated tremor ataxia syndromeW Chonchaiya, D V Nguyen, J Au, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|November 13, 2009
Psychological symptoms correlate with reduced hippocampal volume in fragile X premutation carriersP E Adams, J S Adams, D V Nguyen, et al.
Neurology|December 7, 2007
FMR1 CGG repeat length predicts motor dysfunction in premutation carriersM A Leehey, E Berry-Kravis, C G Goetz, et al.
Brain : a Journal of Neurology|December 8, 2005
Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS)C M Greco, R F Berman, R M Martin, et al.
American Journal of Human Genetics|April 6, 2004
Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutationR J Hagerman, B R Leavitt, F Farzin, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 15, 2017
Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia SyndromeJ Y Wang, A M Trivedi, N R Carrillo, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 30, 2021
A white paper on a neurodevelopmental framework for drug discovery in autism and other neurodevelopmental disordersC M Díaz-Caneja, M W State, R J Hagerman, et al.
Pageof 11